PTSD drug trial halted early: could brexanolone ease trauma?
Symptom relief
Terminated
This pilot study tested a 24-hour IV infusion of brexanolone in 10 adult women with PTSD from non-military trauma. The goal was to see if it could reduce PTSD symptoms and lead to remission by 12 weeks. The trial was terminated early, so results are limited.
Phase: PHASE4 • Sponsor: Donald Jeffrey Newport • Aim: Symptom relief
Last updated Jun 15, 2026 19:07 UTC